MET097 clinical trials

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

This study looks at a new weekly injection, MET097, for adults who are overweight or have obesity. It checks how well it helps with weight loss and if it's safe. The study lasts for 84 weeks, focusing on participants without type 2 diabetes.